DAL
61
3
TROW
32
3
BAX
45
4
CHD
58
2
PFE
35
3
GE
84
2
OKE
73
2
ORCL
77
4
BK
69
3
PNR
72
3
HCP
68
2
APA
24
4
ABBV
59
4
STX
56
-3
HP
41
3
DIS
58
4
KEY
50
3
BF.B
53
-4
JPM
55
3
PG
55
4
DAL
61
3
TROW
32
3
BAX
45
4
CHD
58
2
PFE
35
3
GE
84
2
OKE
73
2
ORCL
77
4
BK
69
3
PNR
72
3
HCP
68
2
APA
24
4
ABBV
59
4
STX
56
-3
HP
41
3
DIS
58
4
KEY
50
3
BF.B
53
-4
JPM
55
3
PG
55
4
Financhill
Back

Catalyst Pharmaceuticals Vs. Edgewise Therapeutics Industry Stock Comparison

Sell
50

CPRX
Catalyst Pharmaceuticals

Last Price:
20.50
Seasonality Move:
-9.09%
Sell
38

EWTX
Edgewise Therapeutics

Last Price:
18.21
Seasonality Move:
-1.28%
Sell
50
Catalyst Pharmaceuticals (CPRX) is a Sell

Is Catalyst Pharmaceuticals a Buy, Sell or Hold?

  • The current Catalyst Pharmaceuticals [CPRX] share price is $20.44. The Score for CPRX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Edgewise Therapeutics (EWTX) is a Sell

Is Edgewise Therapeutics a Buy, Sell or Hold?

  • The current Edgewise Therapeutics [EWTX] share price is $16.86. The Score for EWTX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • EWTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CPRX Stock Price Chart

What is Catalyst Pharmaceuticals's stock price today?

  • The Catalyst Pharmaceuticals share price today is $20.44
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing slight buying pressure.

EWTX Stock Price Chart

What is Edgewise Therapeutics's stock price today?

  • The Edgewise Therapeutics share price today is $16.86
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EWTX is experiencing selling pressure, which indicates risk of future bearish movement.

CPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.42 Buy
Relative Strength Index (14 RSI): 62.28 Buy
Chaikin Money Flow: 182973 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.57 - 20.45) Buy
Bollinger Bands (100): (15.12 - 18.92) Buy

EWTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 42.69 Sell
Chaikin Money Flow: -782567 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.23 - 19.47) Sell
Bollinger Bands (100): (16.65 - 20.15) Sell

CPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.86 Buy
20-day SMA: 20.12 Buy
50-day SMA: 18.42 Buy
200-day SMA: 16.06 Buy
8-day EMA: 20.03 Buy
20-day EMA: 19.75 Buy
50-day EMA: 18.69 Buy
200-day EMA: 16.42 Buy

EWTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.5 Sell
20-day SMA: 18.51 Sell
50-day SMA: 18.91 Sell
200-day SMA: 16.32 Buy
8-day EMA: 17.66 Sell
20-day EMA: 18.01 Sell
50-day EMA: 18.28 Sell
200-day EMA: 16.16 Buy

Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.10 per share, an increase this year of $0.05 per share, and an increase next year of $0.20 per share.

Edgewise Therapeutics Earnings Growth & EWTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.09 per share, an increase this year of $0.05 per share, and a decrease next year of $0.36 per share.

Catalyst Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Edgewise Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):